0001829126-22-019454.txt : 20221121 0001829126-22-019454.hdr.sgml : 20221121 20221121170030 ACCESSION NUMBER: 0001829126-22-019454 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20221121 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221121 DATE AS OF CHANGE: 20221121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Organicell Regenerative Medicine, Inc. CENTRAL INDEX KEY: 0001557376 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790] IRS NUMBER: 474180540 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55008 FILM NUMBER: 221406541 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 300 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 888-963-7881 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 300 CITY: MIAMI STATE: FL ZIP: 33136 FORMER COMPANY: FORMER CONFORMED NAME: Biotech Products Services & Research, Inc. DATE OF NAME CHANGE: 20150917 FORMER COMPANY: FORMER CONFORMED NAME: BESPOKE TRICYCLES INC DATE OF NAME CHANGE: 20120831 8-K 1 organicellregen_8k.htm 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 21, 2022

ORGANICELL REGENERATIVE MEDICINE, INC.

(Exact name of registrant as specified in its charter)

Nevada		000-55008		47-4180540
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1951 NW 7^th Avenue, Suite 300, Miami,

Florida

33136

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (888) 963-7881

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class		Trading Symbol		Name of each exchange on which registered
None		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As used in this Current Report on Form 8-K (this “Report”), and unless otherwise indicated, the terms “the Company,” “Organicell,” “we,” “us” and “our” refer to Organicell Regenerative Medicine, Inc. and its subsidiaries.

Item 8.01

Other Information.

On November 21, 2022, the Company issued a press release responding to recent promotional activities pursuant to OTC Markets request.

A copy of the press release is filed with this Report as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits

Exhibit No.		Description
99.1		Press Release dated November 21, 2022

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 21, 2022	ORGANICELL REGENERATIVE MEDICINE, INC.

	By:	/s/ Ian Bothwell
		Ian Bothwell Chief Financial Officer

2

EX-99.1 2 organicellregen_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Organicell Regenerative Medicine, Inc. Responds to Recent Promotional Activities Pursuant to OTC Markets Request

Davie, Florida – November 21, 2022 – Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) (“Organicell” or the “Company”) has been requested by OTC Markets Group, Inc. (“OTC Markets”) to issue this statement about promotional activity concerning its common stock.

On November 17, 2022, OTC Markets notified the Company of the distribution of three promotional e-mail newsletters (the “Newsletters”), each dated November 15, 2022. The three email newsletters were published by Wall Street Alerts, Epic Stocks Picks and Green Leaf Pot Stocks, respectively, and discussed, among other matters, the Company, its present and planned products, the potential market for its products and the potential for upside in the trading price of the stock. The publications also contained a summary of several recent press releases issued by the Company. OTC Markets provided the Company with the Newsletters for reference. The Company was not aware of the Newsletters prior to receiving them from OTC Markets.

The Company takes its investor relations practices seriously, including its obligations to timely and accurately release material information which might reasonably be expected to have significant effect on the market price or value of its securities. Specific claims in the Newsletters concerning the Company's stock and its upside are highly speculative and should be carefully evaluated based on the Company's latest filings on sec.gov.

The Company has been a fully reporting company, filing periodic reports under the Section 13 of the Securities Exchange Act of 1934, since June 2013 and has had its common stock quoted on OTCQB since November 9, 2021.

In connection with the Company's efforts to increase its brand and company awareness in the investment community and securities markets, in August 2022, the Company engaged TraDigital Marketing Group (“TraDigital”) to provide investor and public relations services designed to assist Organicell in achieving its goal of raising the Company’s profile in the investment community and securities markets, though, among other actions, making introductions to investment banks and broker-dealer firms, attorneys, consultants, public relations firms, investor relations firms, brand awareness firms, and digital marketing companies.

From August through November 2022, TraDigital and its affiliated firm, worked with several firms to increase awareness of the Company. Additionally, as is required of a public company, Organicell issued a number of press releases during that period, reporting material developments and accomplishments, most of which were also filed under the cover of Current Reports on Form 8-K with the Securities and Exchange Commission. These press releases have also been included on the Company's page on the OTC Markets website.

To assist TraDigital in its efforts on behalf of the Company, Organicell furnished TraDigital with copies of its periodic reports filed with the Securities and Exchange Commission, its press releases and an investor presentation, which was filed with the SEC as “7.01 Regulation FD Disclosure” in a Current Report on Form 8-K on October 12, 2022.

As part of its engagement, TraDigital and its affiliated firm engaged one or more outside firms to provide marketing services.

To the Company's knowledge, each of Wall Street Alerts, Epic Stock Picks and Green Leaf Pot Stocks is a third-party marketing and advertising firm that provides content distribution and advertising services. Both Epic Stock Picks and Green Leaf Pot Stocks state that their newsletters are owned and operated by Link Media.

Each of the Newsletters presented factual statements regarding the Company, its current and planned business and industry, seemingly drawn from the Company's SEC filings. Neither the Company nor TraDigital viewed or had any editorial control over the materials, and did not review the materials for factual accuracy or even see them prior to their dissemination. While the Company does not believe the factual statements in the Newsletters that were based on Organicell’s SEC filings and press releases were false or misleading, both newsletters included information and language that went beyond the factual statements in the Company's SEC filings and press releases. As noted, neither the Company nor TraDigital had any control over the content of the promotional materials.

The Company has no knowledge or opinion about whether the Newsletters affected trading activity, however, the Company acknowledges that trading volume on November 15, 2022, the date of the publication of the Newsletters, was significantly higher than previous daily volume levels, and that the trading price experienced an increase on that date compared to that of prior trading days.

As noted, neither the Company nor its officers or directors was involved with the creation of the information in the email Newsletters, other than the information that was gleaned from the Company’s SEC filings and press releases, which were prepared and issued by the Company.

After due inquiry, the Company confirms that it is not aware of any of its control persons, officers, directors, or any shareholders owning 10% or more of the Company's securities, that may have, directly or indirectly, been involved in any way with the creation or distribution of promotional materials related to the Company and its securities, other than the preparation of the Company's SEC filings and related press releases, the substance of which were included in the referenced Newsletters. As noted above, TraDigital and its affiliated firm were involved in engaging the outside marketing firm that engaged Wall Street Alerts, Epic Stock Picks and Green Leaf Pot Stocks, and advanced funds to the outside marketing firm for partial payment of the marketing services. However, neither TraDigital nor its affiliated firm was involved in the creation or distribution of the email newsletters or any other promotional materials.

After due inquiry of management, the directors, control persons, and any third-party service providers, the Company can confirm that neither the Company, its control persons, officers, directors, any controlling shareholders, or any third-party service providers have sold or purchased the Company's securities within the past 90 days, except for transactions that have been reported in the Company’s SEC filings.

1

Other than as disclosed above, the Company has not engaged any third-party providers to provide investor relations services, public relations services, marketing, or other related services including the promotion of the Company or its securities in the last twelve months.

Since August 2022, the Company has not issued any shares of common stock or convertible instruments allowing conversion to equity securities at prices that constituted a discount to the current market rate at the time of the issuance.

About Organicell Regenerative Medicines, Inc.

Organicell Regenerative Medicine, Inc. (OTCQB: OCEL) is a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and the provision of other related services. The Company’s proprietary products are derived from perinatal sources and manufactured to retain the naturally occurring exosomes, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent. To learn more, please visit https://organicell.com/.

Forward-Looking Statements

Certain statements contained in this press release should be considered forward-looking statements within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by the use of forward-looking terminology such as “will,” “believes,” “expects,” “potential,” or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. We remind you that actual results could vary dramatically as a result of known and unknown risks and uncertainties, including but not limited to: potential issues related to our financial condition, competition, the ability to retain key personnel, product safety, efficacy and acceptance, the commercial success of any new products or technologies, success of clinical programs, ability to retain key customers, our inability to expand sales and distribution channels, legislation or regulations affecting our operations including product pricing, reimbursement or access, the ability to protect our patents and other intellectual property both domestically and internationally, and other known and unknown risks and uncertainties, including the risk factors discussed in the Company’s periodic reports that are filed with the SEC and available on the SEC’s website (http://www.sec.gov). You are cautioned not to place undue reliance on these forward-looking statements. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Specific information included in this press release may change over time and may or may not be accurate after the date of the release. Organicell has no intention and specifically disclaims any duty to update the information in this press release.

Investor Relations and Media Relations Contact

Organicell Investor Relations
1-888-963-7881 Ext.701
IR@organicell.com

2

EX-101.SCH 3 ocel-20221121.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ocel-20221121_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ocel-20221121_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Nov. 21, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 21, 2022
Entity File Number	000-55008
Entity Registrant Name	ORGANICELL REGENERATIVE MEDICINE, INC.
Entity Central Index Key	0001557376
Entity Tax Identification Number	47-4180540
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	1951 NW
Entity Address, Address Line Two	7th Avenue
Entity Address, Address Line Three	Suite 300
Entity Address, City or Town	Miami
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33136
City Area Code	(888)
Local Phone Number	963-7881
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false

XML 7 organicellregen_8k_htm.xml IDEA: XBRL DOCUMENT 0001557376 2022-11-21 2022-11-21 iso4217:USD shares iso4217:USD shares 0001557376 false 8-K 2022-11-21 ORGANICELL REGENERATIVE MEDICINE, INC. NV 000-55008 47-4180540 1951 NW 7th Avenue Suite 300 Miami FL 33136 (888) 963-7881 false false false false false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 21 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://organicell.com/role/Cover Cover Cover 1 false false All Reports Book All Reports organicellregen_8k.htm ocel-20221121.xsd ocel-20221121_lab.xml ocel-20221121_pre.xml organicellregen_ex99-1.htm http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "organicellregen_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "organicellregen_8k.htm" ] }, "labelLink": { "local": [ "ocel-20221121_lab.xml" ] }, "presentationLink": { "local": [ "ocel-20221121_pre.xml" ] }, "schema": { "local": [ "ocel-20221121.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 21, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ocel", "nsuri": "http://organicell.com/20221121", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "organicellregen_8k.htm", "contextRef": "From2022-11-21to2022-11-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://organicell.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "organicellregen_8k.htm", "contextRef": "From2022-11-21to2022-11-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://organicell.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 14 0001829126-22-019454-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-22-019454-xbrl.zip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end